Patent Assignment
Reel/Frame 036254/0792
Release of Security Interest
Recorded: 2015-08-03
Pages: 7
Assignor
M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Executed: 2015-07-29
Assignee
VTVX HOLDINGS I LLC
4170 MENDENHALL OAKS PKWY, HIGH POINT, NORTH CAROLINA, 27265
Covered Properties
(49)
Substituted Imidazoles, Their Preparation and Use
Patent:
6,908,926 →
Application:
09/548,081 →
New Compounds, Their Preparation and Use
Patent:
6,972,294 →
Application:
09/551,740 →
Peroxisome Proliferator-Activated Receptor (Ppar) Active Vinyl Carboxylic Acid Derivatives
Novel Aminoazetidine,-Pyrrolidine and -Piperidine Derivatives
Compounds, Their Preparation and Use
Substituted Hexahydropyrrolo[1,2-a]Pyrazines, Octahydropyrido[1,2-a]-Pyrazines and Decahydropyrazino[1,2-A]Azepines
Peroxisome Proliferator Acticvated Receptor-Active Arylene Acetic Acid Derivatives
Substituted Homopiperidine, Piperidine or Pyrrolidine Derivatives
Pharmaceutical Use of Fused 1,2,4-Triazoles
Combination Therapy Using an 11BETA-Hydroxysteroid Dehydrogenase Type 1 Inhibitor and an Antihypertensive Agent for the Treatment of Metabolic Syndrome and Related Diseases and Disorders
Bissulfonamide Compounds as Agonists of GALR1, Compositions, and Methods of Use
Novel Piperazines
11BETA-Hydroxysteroid Dehydrogenase Type 1 Active Spiro Compounds
Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
Phenoxy Acetic Acids as Ppar Delta Activators
Novel Medicaments
Novel Compounds, Their Preparation and Use
Benzothiazoles Having Histamine H3 Receptor Activity
6- (4-Cyclopropylpiperazin-1-Yl) -2 ' -Methyl- [3, 4 ' ] -Bipyridine and Its Use as a Medicament
3-(L,3-Benzodioxol-5-Yl)-6-(4-Cyclopropylpiperazin-L-Yl)-Pyridazine, Its Salts and Solvates and Its Use as Histamine H3 Receptor Antagonist
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis
Pharmaceutical Use of Substituted Amides
Heterocyclic H3 Antagonists
Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Substituted Imidazo[1,2-B]Pyridazine Derivatives, Pharmaceutical Compositions, and Methods of Use as Beta-Secretase Inhibitors
Phenyl Propionic Acids as Ppar Delta Activators
Phenoxy Acetic Acids as Ppar Delta Activators
Adamantyl Benzamide Derivatives
Substituted Thiazol-2-Ylamine Derivatives, Pharmaceutical Compositions, and Methods of Use as 11-Beta HSD1 Modulators
Substituted Isoquinoline Derivatives, Pharmaceutical Compositions, and Methods of Use as Beta-Secretase Inhibitors
11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Phenoxy Acetic Acids as Ppar Delta Activators
Novel Medicaments
Benzothiazoles Having Histamine H3 Receptor Activity
Phenoxy Acetic Acids as Ppar Delta Activators
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Compounds That Modulate Oxidative Stress
Phenoxy Acetic Acids and Phenyl Propionic Acids as Ppar Delta Agonists
Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
N-Adamantyl Benzamides as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Use of a Ppar-Delta Agonist for Treating Muscle Atrophy
Bach1 Inhibitors in Combination with Nrf2 Activators and Pharmaceutical Compositions Thereof
Application:
62/085,875 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Aug 9, 2013
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0793 →
Notice of Release of Security Interest in Patents for Reel/Frame 030982/0793
Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: HIGH POINT PHARMACEUTICALS, LLC
Reel/Frame 032621/0867 →
Security Interest
Feb 26, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0029 →
Change of Name
Jul 30, 2015
From: HIGH POINT PHARMACEUTICALS, LLC
To: VTVX HOLDINGS II LLC
Reel/Frame 036236/0159 →
Assignment of Assignor's Interest
Jul 31, 2015
From: VTVX HOLDINGS II LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0362 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 036254 Frame: 0792. Assignor(S) Hereby Confirms the Assignment.
Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036675/0399 →